Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-018616
Filing Date
2012-03-30
Accepted
2012-03-30 14:20:33
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v306005_10k.htm 10-K 634804
2 EXHIBIT 31.1 v306005_ex31-1.htm EX-31.1 10530
3 EXHIBIT 31.2 v306005_ex31-2.htm EX-31.2 10521
4 EXHIBIT 32 v306005_ex32.htm EX-32 3802
  Complete submission text file 0001144204-12-018616.txt   2299686

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20111231.xml EX-101.INS 217528
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20111231.xsd EX-101.SCH 18922
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20111231_cal.xml EX-101.CAL 24066
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20111231_def.xml EX-101.DEF 74293
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20111231_lab.xml EX-101.LAB 167623
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20111231_pre.xml EX-101.PRE 100467
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 12728089
SIC: 2834 Pharmaceutical Preparations